T1	Pharmacological_substance 15 43	serotonergic antidepressants
T2	Pharmacological_substance 48 65	opioid analgesics
N1000 	Reference T2 MeSH:D000701	opioid analgesics
T3	Disorder 70 88	serotonin syndrome
N1 	Reference T3 UMLS:C0024586	serotonin syndrome
N2 	Reference T3 UMLS:C0699828	serotonin syndrome
T4	Pharmacological_substance 157 164	opioids
N1001 	Reference T4 MeSH:D000701	opioids
T5	Pharmacological_substance 169 197	serotonergic antidepressants
T6	Disorder 228 246	serotonin syndrome
N3 	Reference T6 UMLS:C0024586	serotonin syndrome
N4 	Reference T6 UMLS:C0699828	serotonin syndrome
T7	Pharmacological_substance 457 485	serotonergic antidepressants
T8	Pharmacological_substance 496 534	selective serotonin reuptake inhibitor
N1002 	Reference T8 MeSH:D017367	selective serotonin reuptake inhibitor
T9	Pharmacological_substance 536 540	SSRI
N1003 	Reference T9 MeSH:D017367	SSRI
N1004 	Reference T9 MeSH:D017367	SSRI
T10	Pharmacological_substance 545 556	mirtazapine
N1005 	Reference T10 MeSH:C035133	mirtazapine
T11	Pharmacological_substance 561 568	opioids
N1006 	Reference T11 MeSH:D000701	opioids
T13	Disorder 693 711	serotonin toxicity
T14	Disorder 724 745	visual hallucinations
N5 	Reference T14 UMLS:C0233763	visual hallucinations
T15	Disorder 747 762	muscle rigidity
N6 	Reference T15 UMLS:C0026837	muscle rigidity
T16	Disorder 764 773	myoclonus
N7 	Reference T16 UMLS:C0027066	myoclonus
T17	Disorder 778 790	hypertension
N8 	Reference T17 UMLS:C0020538	hypertension
T18	Pharmacological_substance 813 819	opiate
N1007 	Reference T18 MeSH:D053610	opiate
T19	Pharmacological_substance 828 832	SSRI
N1008 	Reference T19 MeSH:D017367	SSRI
N1009 	Reference T19 MeSH:D017367	SSRI
T20	Disorder 836 844	lethargy
N9 	Reference T20 UMLS:C0023380	lethargy
T21	Disorder 846 857	hypotension
N10 	Reference T21 UMLS:C0020649	hypotension
T22	Disorder 863 870	hypoxia
N11 	Reference T22 UMLS:C0242184	hypoxia
T23	Pharmacological_substance 891 899	tramadol
N1010 	Reference T23 MeSH:D014147	tramadol
T24	Pharmacological_substance 904 915	mirtazapine
N1011 	Reference T24 MeSH:C035133	mirtazapine
T25	Pharmacological_substance 965 993	serotonergic antidepressants
T26	Pharmacological_substance 998 1005	opioids
N1012 	Reference T26 MeSH:D000701	opioids
T27	Pharmacological_substance 1185 1189	SSRI
N1013 	Reference T27 MeSH:D017367	SSRI
N1014 	Reference T27 MeSH:D017367	SSRI
T28	Pharmacological_substance 1193 1204	mirtazapine
N1015 	Reference T28 MeSH:C035133	mirtazapine
T29	Pharmacological_substance 1225 1232	opioids
N1016 	Reference T29 MeSH:D000701	opioids
T33	Disorder 303 305	SS
N12 	Reference T33 UMLS:C0024586	SS
N13 	Reference T33 UMLS:C0699828	SS
T34	Speculation_cue 123 132	potential
T35	Subject 309 326	elderly residents
T36	Subject 416 443	Four elderly LTCF residents
T39	Disorder 603 605	SS
N14 	Reference T39 UMLS:C0024586	SS
N15 	Reference T39 UMLS:C0699828	SS
T40	Subject 648 675	elderly residents of a LTCF
T41	Disorder 639 641	SS
N16 	Reference T41 UMLS:C0024586	SS
N17 	Reference T41 UMLS:C0699828	SS
T42	Disorder 1076 1078	SS
N18 	Reference T42 UMLS:C0024586	SS
N19 	Reference T42 UMLS:C0699828	SS
T43	Disorder 1157 1159	SS
N20 	Reference T43 UMLS:C0024586	SS
N21 	Reference T43 UMLS:C0699828	SS
T44	Disorder 1066 1068	SS
N22 	Reference T44 UMLS:C0024586	SS
N23 	Reference T44 UMLS:C0699828	SS
T52	Subject 1023 1039	some individuals
T54	Speculation_cue 1057 1061	risk
T57	Speculation_cue 1142 1153	possibility
T60	Disorder 248 250	SS
N24 	Reference T60 UMLS:C0024586	SS
N25 	Reference T60 UMLS:C0699828	SS
T47	Combination 820 824	with
T50	Combination 900 903	and
T51	Combination 945 961	coadministration
T55	Combination 1208 1219	combination
T38	Combination 557 560	and
